Increased Cardiac Troponin-T in Patients without Myocardial Infarction
https://doi.org/10.15360/1813-9779-2008-4-36
Abstract
There have been recently reports on elevated levels of cardiac troponins in patients without acute myocardial infarction (AMI). The purpose of the study was to analyze final diagnoses in patients with elevated cardiac troponin-T levels without clinical manifestations and characteristic ECG changes in AMI. Subjects and materials. The study included 72 patients (48 males and 24 females whose age ranged from 54 to 87 years (mean 69.8±11.2 years)). The criterion for inclusion was increased cardiac troponin-T; the primary criteria for exclusion were AMI-specific anginal pains and characteristic ECG changes (ST-segment elevation, abnormal Q waves). The definitive diagnosis of AMI was established only in 29 (40.3%) patients; the remaining 43 patients were diagnosed as having the following diseases: sepsis (n=21), cancer (n=10), diabetic nephropathy with chronic renal failure (n=6), cerebral infarction (n=4), and B12-deficiency anemia (n=2). In deceased patients, the level of troponin-T was higher than that in those who was discharged from hospital irrespective of the underlying disease. Results. There was a direct correlation between the level of cardiac troponin-T and the SAPS II index that reflects the general condition of a patient (r=0.44; p=0.0001) and an inverse correlation between the former and the left ventricular ejection fraction (r=-0.45; p=0.003). Conclusion. Thus, despite its cardiac specificity and its detection in the blood of critically ill patients without other manifestations of AMI, cardiac troponin-T is not a specific symptom of AMI, but suggests the severity of the disease, possibly, with the involvement of the myocardium in the pathological process. Key words: cardiac troponins, myocardial infarction, multiple organ dysfunction, systemic inflammatory reaction.
About the Authors
M. Ya. KrasnoselskyYe. V. Koshkina
N. M, Fedorovsky
Ye. V. Goryacheva
A. A. Polupan
A. A. Arefyev
M. Z. Bratanova
References
1.
2. Braunwald E., Antman E. M., Beasley J. W. et al.ACC/AHA guidelines for the management of patients with unstable angina and non-ST-seg-ment elevation myocardial infarction: a report of the American college of cardiology/american heart association task force on practice guidelines. J. Am. Coll. Cardiol. 2000; 36: 970—106
3. Alpert J. S., Thygesen K., Antman E. et al.Myocardial infarction redefined: a consensus document of the joint european society of cardiology/american college of cardiology committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 2000; 36: 959—969.
4. Collins P. O., Gaze D. C.Biomarkers of cardiovascular damage. Med. Princ. Pract. 2007; 16: 247—261.
5. Coudrey L.The troponins. Arch. Int. Med. 1998; 158: 1173—1180.
6. Ammann P., Pfisterer M., Fehr T. et al.Raised cardiac troponins. B.M.J. 2004; 328: 1028—1029.
7. Kontos M. C., Fritz L. M., Anderson F. P. et al.Impact of the troponin standard on the prevalence of acute myocardial infarction. Am. Heart J. 2003; 146: 446—452.
8. Ferguson J. L., Beckett G. J., Stoddart M. et al.Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart 2002; 88: 343—347.
9. Guest T. M., Ramanathan A. V., Tuteur P. G. et al.Myocardial injury in critically ill patients: a frequently unrecognized complication. T.A.M.A. 1995; 273: 1945—194
10. Turner A., Tsamitros M., Bellomo R.Myocardial cell injury in septic shock. Crit. Care Med. 1999; 27: 1775—1780.
11. Ammann P., Fehr T., Minder E. I. et al.Elevation of troponin I in sepsis and septic shock. Intens. Care Med. 2001; 27: 965—969.
12. Le Gall J.R., Lemeshow S., Saulnier F.A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. J.A.M.A. 1993; 270: 2957—2963.
13. Wu A. H.Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intens. Care Med. 2001; 27: 959—961.
14. Wong P., Mussay S., Ramsewak A. et al.Raise cardiac troponin T levels in patients without acute coronary syndrome. Postgrad. Med. 2007; 83: 200—205.
15. Ammann P., Maggiorini M.Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. Am. Coll. Cardiol. 2003; 41: 2004—2009.
16. Afessa B., Green B., Delke I., Koch K.Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU. Chest 2001; 120: 1271—1277.
17. Matsuda N., Hattori Y.Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J. Pharmacol. Sci. 2006; 101: 189—198.
18. Kaye A. D., Hoover J. M., Baluch A. R.A contemporary review of multiple organ failure. Middle East J. Anesthesiol. 2005; 18: 273—292.
19. Rudiger A., Singer M.Mechanisms of sepsis-induced cardiac dysfunction. Crit. Care Med. 2007; 35: 1599—1608.
20. Piper H.M., Schwartz P., Spahr R. et al.Early enzyme release from myocardial cells is not due to irreversible cell damage. J. Mol. Cell. Cardiol. 1984; 16: 385—388.
21. Wu A. H., Ford L.Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin. Chim. Acta 1999; 284: 161—174.
22. Babuin L., Jaffe A. S.Troponin: the biomarker of choice for the detection of cardiac injury C.M.A.J. 2005; 173: 1191—1202.
23. Wu A. H.Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 2001; 27: 959—961.
24. Ver Elst K. M., Spapen H. D., Nguyen D. N. et al.Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin. Chem., 2000; 46: 650—657.
Review
For citations:
Krasnoselsky M.Ya., Koshkina Ye.V., Fedorovsky N.M., Goryacheva Ye.V., Polupan A.A., Arefyev A.A., Bratanova M.Z. Increased Cardiac Troponin-T in Patients without Myocardial Infarction . General Reanimatology. 2008;4(4):36. (In Russ.) https://doi.org/10.15360/1813-9779-2008-4-36
Views:
4055
Email this article 